glp-1 news today receptor agonists show promise in treating substance use disorders GLP-1 News Roundup: 12 Massive

Reduces the Risk of Rebound Weight Gain Clinical follow-up shows that GLP-1 users commonly regain 6690% of lost weight within one year after stopping injections

Check the manufacturer websites for current offers

Safety Considerations for Combining Weight Loss and Antidepressant Therapy Blood pressure monitoring becomes especially important when using semaglutide and bupropion together, since bupropion can moderately elevate systolic and diastolic readings in some patients

Common triggers for telogen effluvium include: Rapid weight loss Major surgery or illness High fevers Childbirth Significant emotional or physical stress Nutritional deficiencies GLP-1associated shedding fits this pattern almost perfectly

Patients who experience rapid dose escalation may be more prone to fatigue and gastrointestinal symptoms